Adjuvant Chemotherapy for Locally Advanced Cervical Cancer
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Data of survival benefit from adjuvant chemotherapy (ACT) after concurrent chemoradiation
(CCRT) for locally advanced cervical cancer (LACC) are still limited and inconsistent. We
will investigate if ACT has survival benefit over CCRT alone.
Phase:
Phase 3
Details
Lead Sponsor:
Siriwan Tangjitgamol, MD
Collaborators:
Bhumibol Adulyadej Hospital Chiang Mai University Chonburi Cancer Hospital Chulalongkorn University Health Intervention and Technology Assessment Program Lampang Cancer Hospital Lopburi Cancer Hospital National Research Council of Thailand Navamindradhiraj University Prince of Songkla University Rajburi Hospital Ubonratchathani Cancer Hospital Udonthani Cancer Hospital